Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats P Tétreault, MA Dansereau, L Doré-Savard, N Beaudet, P Sarret Physiology & behavior 104 (3), 495-502, 2011 | 109 | 2011 |
Central delivery of Dicer-substrate siRNA: a direct application for pain research L Doré-Savard, G Roussy, MA Dansereau, MA Collingwood, KA Lennox, ... Molecular Therapy 16 (7), 1331-1339, 2008 | 77 | 2008 |
Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain L Doré-Savard, V Otis, K Belleville, M Lemire, M Archambault, L Tremblay, ... PLoS One 5 (10), e13774, 2010 | 72 | 2010 |
Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model G Roussy, MA Dansereau, L Doré‐Savard, K Belleville, N Beaudet, ... Journal of neurochemistry 105 (4), 1100-1114, 2008 | 64 | 2008 |
The angiogenic secretome in VEGF overexpressing breast cancer xenografts L Dore-Savard, E Lee, S Kakkad, AS Popel, ZM Bhujwalla Scientific reports 6 (1), 39460, 2016 | 35 | 2016 |
A micro-imaging study linking bone cancer pain with tumor growth and bone resorption in a rat model L Doré-Savard, N Beaudet, L Tremblay, Y Xiao, M Lepage, P Sarret Clinical & experimental metastasis 30, 225-236, 2013 | 20 | 2013 |
Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment B Krishnamachary, Y Mironchik, D Jacob, E Goggins, S Kakkad, F Ofori, ... Neoplasia 22 (12), 679-688, 2020 | 18 | 2020 |
Direct application of siRNA for in vivo pain research P Sarret, L Doré-Savard, N Beaudet RNA Interference: From Biology to Clinical Applications, 383-395, 2010 | 13 | 2010 |
Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging L Doré-Savard, DA Barrière, E Midavaine, D Bélanger, N Beaudet, ... Journal of Nuclear Medicine 54 (6), 944-952, 2013 | 11 | 2013 |
Application of dicer-substrate siRNA in pain research P Sarret, L Doré-Savard, P Tétreault, V Bégin-Lavallée, N Beaudet RNA technologies and their applications, 161-190, 2010 | 6 | 2010 |
Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management DA Barrière, É Midavaine, L Doré-Savard, K Kirby, L Tremblay, ... Scientific Reports 9 (1), 20155, 2019 | 4 | 2019 |
Delayed progression of lung metastases following delivery of a prodrug-activating enzyme L Dore-Savard, Z Chen, PT Winnard, B Krishnamachary, V Raman, ... Anticancer research 37 (5), 2195-2200, 2017 | 2 | 2017 |
Metabolic profiling of the tumor interstitial fluid using 1H MRS: contribution of breast cancer subtypes and VEGF overexpression L Dore-Savard, SK Bharti, AS Popel, ZM Bhujwalla Cancer Research 76 (14_Supplement), 3370-3370, 2016 | 2 | 2016 |
Using RNA Interference to Downregulate G Protein-Coupled Receptors P Sarret, L Doré-Savard, P Tétreault, V Bégin-Lavallée, MA Dansereau, ... Methods for the Discovery and Characterization of G Protein-Coupled …, 2011 | 2 | 2011 |
Publisher Correction: Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management DA Barrière, É Midavaine, L Doré-Savard, K Kirby, L Tremblay, ... Scientific Reports 10, 2020 | 1 | 2020 |
COX-2 alters the metabolic secretome in triple negative human breast cancer xenografts SK Bharti, PT Winnard, Y Mironchik, L Dore-Savard, B Krishnamachary, ... Cancer Research 78 (13_Supplement), 3480-3480, 2018 | 1 | 2018 |
Analgesic effects of neurotensin agonists in a rat bone cancer pain model L Doré-Savard, P Tetreault, M Roux, M Martel, M Lemire, K Belleville, ... bioRxiv, 089169, 2016 | 1 | 2016 |
Combining parallel multiresolution and PCA initialization for a fully automatic PET-MRI registration M Bernier, M Lepage, R Lecomte, L Tremblay, L Doré-Savard, ... ISMRM 2011, 3255, 2011 | 1 | 2011 |
Mechanisms of bone cancer pain L Doré-Savard, N Beaudet, P Sarret Landmark Papers in Pain: Seminal Papers in Pain with Expert Commentaries 171 …, 2018 | | 2018 |
Ablation of parathyroid hormone-related protein in the triple negative human breast cancer line MDA-MB-231 inhibits its cancer stem cell phenotype J Li, L Doré-Savard, K Sellin, A Camirand, R Kremer Cancer Research 78 (13_Supplement), 3062-3062, 2018 | | 2018 |